OmniAb, Inc. (OABI)
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
$4.83-6.76%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-05
QuarterlyIQ Insights · OABI
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 40.2 | 18.7 | 26.4 | 34.2 | 59.1 | — | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 42.7 | 47.8 | 55.1 | 56.5 | 48.4 | — | — |
| Other Operating Expenses, Total | (0.5) | 2.5 | 2.4 | (0.2) | 0.6 | — | — |
| Operating Income | (46.6) | (69.0) | (74.5) | (69.4) | (26.6) | — | — |
| Earnings from Continuing Operations | |||||||
| Interest & Investment Income | 2.7 | 2.7 | 3.1 | 5.1 | 0.6 | — | — |
| Other Non-Operating Income / Expenses | 2.7 | 2.7 | 3.1 | 5.1 | 0.6 | — | — |
| EBT, Incl. Unusual Items | (43.9) | (66.3) | (71.4) | (64.4) | (26.1) | — | — |
| Income Tax Expense | (0.4) | (1.5) | (9.4) | (13.7) | (3.7) | — | — |
| Net Income | |||||||
| Net Income | (43.5) | (64.8) | (62.0) | (50.6) | (22.3) | (0.5) | — |
| Per Share | |||||||
| Basic EPS | (0.34) | (0.57) | (0.61) | (0.51) | (0.26) | — | — |
| Diluted EPS | (0.34) | (0.57) | (0.61) | (0.51) | (0.26) | — | — |
| Revenue per Share | 0.31 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 129.3 | 113.6 | 102.4 | 99.7 | 85.3 | — | — |
| Diluted Weighted Avg Shares | 129.3 | 113.6 | 102.4 | 99.7 | 85.3 | — | — |
| Supplemental | |||||||
| EBITDA | — | (47.2) | (50.9) | (49.9) | (8.4) | — | — |
| EBIT | (46.6) | (69.0) | (74.5) | (69.4) | (26.6) | — | — |
| Effective Tax Rate | 0.9% | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.